Clinical Trial Update: Neuropathic Pain Syndrome Patient Study (MK-0000-072) [Phase 1]

View source ↗

Summary

A Phase 1 trial of MK-0000-072 sponsored by Merck in patients with various neuropathic conditions; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Idiopathic Distal Sensory Polyneuropathy
• Painful Small-fiber Neuropathy
• Postherpetic Neuralgia

Drugs mentioned

• MK-0000-072

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neuralgia, Postherpetic, Diabetic Neuropathy | Phase 1 | Status: COMPLETED | Results posted: 2010-02-05